Needham & Company
-
StreetInsider.com Pre-Open Movers 5/28: (OMTH) (CSIQ) (VRX) Higher; (EXC) (STJ) (RCL) Lower (more...)
-
Notable Analyst Rating Changes 09/19: (ACHN) (GLW) (AZN) Upgraded; (IDIX) (WM) (SCHW) Downgraded
-
Needham & Company Downgrades Progenics Pharmaceuticals (PGNX) to Hold; Concerns on Lack of Clarity with Relistor
-
Needham & Company on Impax Labs (IPXL): Not a Strategic Game-Change but Zomig Offsets SG&A Ramp and Provides Short-Term EPS Boost
-
Needham & Company Maintains a 'Hold' on Targacept (TRGT); Sidelined Until TC5214 Phase 3 Story in Depression is Fully Resolved
-
Needham & Company Downgrades Targacept (TRGT) to Hold
-
Needham & Company Maintains a 'Buy' on Targacept (TRGT); Expect Continued Positive Results from AZN Collaboration
-
UPDATE - Needham & Company Upgraded Targacept (TRGT) to Strong Buy; Valuation Attractive after Distraction of AstraZeneca TC-5619 Option Decision
-
Notable Analyst Rating Changes 8/20: SOL, JACK, PRU, LULU, CHA Upgraded; RF, BCSI, AZN, BUCY, JOYG, UA Downgraded

